Cardiome Pharma (CRME) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to Cardiome Pharma (CRME) Tops Q3 EPS by 1c

Cardiome Reports Third Quarter 2016 Financial Results

November 7, 2016 8:00 AM EST

Cardiome to conduct conference call and webcast on Monday,  November 7, 2016 at 4:00pm Eastern (1:00pm Pacific)

NASDAQ: CRME TSX: COM

Quarterly Highlights:

Q3 revenue consistent with both quarterly and annual targets. Completed an underwritten equity offering whereby Cardiome issued 11.5 million shares from treasury for gross proceeds of US$34.5 million. Prepared our commercial markets for the imminent launch of XYDALBA. Initiated commercial operations in Canada by putting an acute-care hospital focused sales force in place. Announced that the European Medicines Agency had approved... More